Digipath Files Provisional Patent for Terpene Applications in Beer and other Beverages
05 Mars 2019 - 3:15PM
InvestorsHub NewsWire
Digipath Files Provisional
Patent for Terpene Applications in Beer and other
Beverages
Company Looks to Protect and
Provide Terpene Technology
in
Rapidly Expanding Cannabis
Beverage
Market
LAS VEGAS, NV
-- March 5, 2018 -- InvestorsHub NewsWire
-- Digipath, Inc.
(OTCQB:
DIGP),
a
service-oriented independent testing laboratory, data and media
firm focused on the developing cannabis and hemp
market, is pleased to announce that it has filed a
United States provisional patent application
for “A METHOD FOR AUGMENTING
TERPENE PROFILES IN BEER AND OTHER
BEVERAGES.”
Hops used in the production of beer contain terpenes, which
are lost through the normal brewing process. Still, subtle
undocumented effects may be left behind in the finished
product. Hops cultivators and beer producers currently have
no control over the levels of the various terpenes’ impact as
imparted into the beer products through the use of hops. Just
as cannabis is sold based on its THC content, hops tends to be sold
based on its terpene content. This lack of control extends to the
physiological effects, benefits or lack of benefits to the beer
drinking consumers. Digipath’s technology gives brewers
significant control and accountability for the finished product,
allowing for accurate reporting, marketing, and customer
satisfaction potentially across the entire cannabis-infused
beverage category.
The filing comes at a time when
major beverage companies are aggressively entering the
Cannabis/Beverage space following a decline in beer sales in many
areas after the introduction of legalized cannabis. According
to a
ten-year-long joint study, results showed a 13.8
percent drop in beer
sales after marijuana legalization. Additionally,
data confirms that sales of alcohol were, on average,
fifteen percent lower in states with legalized cannabis. The
same study also showed that marijuana and alcohol have a widely
overlapping consumer base. ( Click here for the full
story.
)
“The underlying method detailed in
this provisional patent can be applied to any individual terpene or
combination of terpenes and can be used to augment any type of
beverage including mimicking of a specific cannabis strain terpene
profile,” stated Dr. Orser. “Terpenes are
major components of plant derived essential oils used by humans for
thousands of years, and they are abundant in unique combinations in
hops. These terpenes can be used to distinguish hops cultivars from
one another and many terpenes have documented physiological effects
in mammals.”
We hope and expect our patents to
be approved and to add this to our ever-growing portfolio of
practical, monetizable cannabis technology,” added Dr.
Orser.
About Digipath, Inc. & Digipath Labs,
Inc.
Digipath,
Inc. supports the
cannabis industry's best practices for reliable testing, data
acquisition, cannabis education and training, and brings unbiased
cannabis news coverage to the cannabis
industry. Digipath
Labs provides
pharmaceutical-grade analysis and testing to the cannabis industry
to ensure producers, consumers, and patients know exactly what is
in the cannabis they ingest and to help maximize the quality of its
client's products through analysis, research, development, and
standardization.
Digipath Investor Relations & Financial
Media
Integrity Investor
Relations
info@integrityir.com
Toll Free: (888) 216-3595
www.IntegrityIR.com
Information
about Forward-Looking Statements
This press release
contains "forward-looking statements" that include information
relating to future events. Forward-looking statements should not be
read as a guarantee of future performance or results and will not
necessarily be accurate indications of the times at, or by, which
that performance or those results will be achieved. Forward-looking
statements are based on information available at the time they are
made and/or management's good faith belief as of that time with
respect to future events and are subject to risks and uncertainties
that could cause actual performance or results to differ materially
from those expressed in, or suggested by, the forward-looking
statements. Important factors that could cause these differences
include, but are not limited to: the Company's need for additional
funding, the demand for the Company's products, governmental
regulation of the cannabis industry, the Company's ability to
maintain customer and strategic business relationships, the impact
of competitive products and pricing, growth in targeted markets,
the adequacy of the Company's liquidity and financial strength to
support its growth, and other risks that may be detailed from
time-to-time in the Company's filings with the United States
Securities and Exchange Commission. For a more detailed description
of the risk factors and uncertainties affecting Digipath, please
refer to the Company's recent Securities and Exchange Commission
filings, which are available at www.sec.gov. The Company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise.
Digipath (PK) (USOTC:DIGP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Digipath (PK) (USOTC:DIGP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Digipath Inc (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Digipath (QB)